PAICS and prostate carcinoma: PAICS, a de novo purine metabolic enzyme, is significantly overexpressed in several tumor types, including lung adenocarcinoma, breast cancer, diffuse large B-cell lymphoma, and prostate cancer (Chakravarthi et al., 2017; Akashi et al., 2019; Zhou et al., 2019).